Abstract:BACKGROUND AND AIMS: Pain is a cardinal symptom of chronic pancreatitis (CP). Using Patient-Reported Outcomes Measurement Information System (PROMIS) measures, we characterized physical and mental health and symptom profiles of a well-defined cohort of individuals with CP and compared them with control subjects. Among patients with CP, we also examined associations between pain (intensity, temporal nature) and PROMIS symptom profiles and the prevalence of clinically significant psychological comorbidities.METHODS: We analyzed baseline data in 488 CP patients and 254 control subjects enrolled in PROCEED (Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies), an ongoing longitudinal cohort study. Participants completed the PROMIS-Global Health, which captures global physical and mental health, and the PROMIS-29 profile, which captures 7 symptom domains. Self-reported pain was categorized by severity (none, mild-moderate, severe) and temporal nature (none, intermittent, constant). Demographic and clinical data were obtained from the PROCEED database.RESULTS: Pain was significantly associated with impairments in physical and mental health. Compared with participants with no pain, CP participants with severe pain (but not mild-moderate pain) had more decrements in each PROMIS domain in multivariable models (effect sizes, 2.54-7.03) and had a higher prevalence of clinically significant depression, anxiety, sleep disturbance, and physical disability (odds ratios, 2.11-4.74). Similar results were noted for constant pain (but not intermittent pain) for PROMIS domains (effect sizes, 4.08-10.37) and clinically significant depression, anxiety, sleep disturbance and physical disability (odds ratios, 2.80-5.38).CONCLUSIONS: Severe and constant pain are major drivers for poor psychological and physical health in CP. Systematic evaluation and management of psychiatric comorbidities and sleep disturbance should be incorporated into routine management of patients with CP. (ClinicalTrials.gov, Number: NCT03099850).

Towards a neurobiological understanding of pain in chronic pancreatitis: mechanisms and implications for treatment

Molecular and Behavioral Changes in Nociception in a Novel Rat Model of Chronic Pancreatitis for the Study of Pain

Serum Biomarkers of Nociceptive and Neuropathic Pain in Chronic Pancreatitis

Recent advances in the understanding and management of chronic pancreatitis pain

Molecular mechanisms of pain in acute pancreatitis: recent basic research advances and therapeutic implications

Neuropancreatology: The Nervous System and Pain Management in Pancreatic Diseases

Neurokinin-2 Receptor Levels Correlate with Intensity, Frequency, and Duration of Pain in Chronic Pancreatitis.

Pain in chronic pancreatitis: What can we do today?

Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain

Association of Chronic Pancreatitis Pain Features With Physical, Mental, and Social Health

Non-pharmacological pain palliation methods in chronic pancreatitis

Understanding pain in acute pancreatitis: A focus on kynurenine pathway dynamics

Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons!

Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain

The Role of Mast Cells in the Pathogenesis of Pain in Chronic Pancreatitis

Individualized Pain Treatment in Chronic Pancreatitis (INPAIN): An International, Multicenter, Investigator-initiated, Prospective, Cohort Study

Pain Management in Chronic Pancreatitis: Summary of Clinical Practice, Current Challenges and Potential Contribution of the M-ANNHEIM Classification

Pain management in chronic pancreatitis

Overexpression of Neurokinin-2 Receptor is Related to Pain in Chronic Pancreatitis

Assessment of visceral pain with special reference to chronic pancreatitis

Acute pancreatitis results in referred mechanical hypersensitivity and neuropeptide up-regulation that can be suppressed by the protein kinase inhibitor k252a